SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-027368
Filing Date
2020-09-18
Accepted
2020-09-18 16:30:30
Documents
13
Period of Report
2020-09-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea127053-8k_intecpharma.htm   iXBRL 8-K 21632
  Complete submission text file 0001213900-20-027368.txt   164146

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ntec-20200916.xsd EX-101.SCH 3442
3 XBRL DEFINITION FILE ntec-20200916_def.xml EX-101.DEF 11083
4 XBRL LABEL FILE ntec-20200916_lab.xml EX-101.LAB 22423
5 XBRL PRESENTATION FILE ntec-20200916_pre.xml EX-101.PRE 11486
6 EXTRACTED XBRL INSTANCE DOCUMENT ea127053-8k_intecpharma_htm.xml XML 2554
Mailing Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512
Business Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512 97225864657
Intec Pharma Ltd. (Filer) CIK: 0001638381 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37521 | Film No.: 201184309
SIC: 2834 Pharmaceutical Preparations